MOLN Competitors & Alternatives
Compare Molecular Partners AG ADR with similar stocks in the same industry
Biotechnology
MOLN
Main Stock$3.01
Tradestie Score
47
Market Cap
$138.88M
Revenue Growth
-1.0%
Analyst Upside
+236.0%
Top Competitors
218 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
FBRX
Forte Biosciences, Inc. Common Stock
|
$76.99
|
$180.53M | - | 54 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$6.78
|
$158.43M | - | 56 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$21.01
|
$154.27M | - | 41 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.83
|
$133.50M | - | 29 | Compare |
|
SRZN
Surrozen, Inc. Common
|
$32.02
|
$117.07M | - | 30 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$32.05
|
$110.20M | - | 41 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.56
|
$97.42M | - | 50 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.23
|
$84.52M | - | 41 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.20
|
$67.94M | - | 46 | Compare |
|
IPSC
Century Therapeutics, Inc. Common Stock
|
$1.64
|
$43.18M | - | 30 | Compare |
More MOLN Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2836)
218 stocks in this industry